TELA Bio, Inc. Common Stock (TELA) Stock Price

TELAStock

$0.97−35.00%52W

Market Cap$44.01M

P/E—

PEG Ratio—

Div yield—

Beta1.43

TELA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)52.03%

Price vs S&P 500 (4W)-23.67%

VGM Score59.83

Book Value / Share (Quarterly)$0.14

P/TBV (Annual)10.61x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)24.68%

Cash Flow / Share (Quarterly)$-0.71

Price vs S&P 500 (YTD)-29.30%

Gross Margin (TTM)67.06%

Net Profit Margin (TTM)-51.53%

EPS (TTM)$-0.77

10-Day Avg Trading Volume0.15M

EPS Excl Extra (TTM)$-0.77

Revenue Growth (5Y)34.54%

EPS (Annual)$-0.83

ROI (Annual)-62.67%

Gross Margin (Annual)67.69%

Net Profit Margin (5Y Avg)-80.54%

Cash / Share (Quarterly)$0.68

Revenue Growth QoQ (YoY)-4.49%

ROA (Last FY)-47.69%

Revenue Growth TTM (YoY)6.09%

EBITD / Share (TTM)$-0.65

ROE (5Y Avg)-294.07%

Operating Margin (TTM)-43.67%

Cash Flow / Share (Annual)$-0.64

P/B Ratio6.97x

P/B Ratio (Quarterly)8.32x

Net Income / Employee (Annual)$-258,900

EV / Revenue (TTM)0.87x

Net Interest Coverage (TTM)-6.36x

ROA (TTM)-60.42%

EPS Incl Extra (Annual)$-0.83

Current Ratio (Annual)4.20x

Quick Ratio (Quarterly)2.20x

3-Month Avg Trading Volume0.19M

52-Week Price Return-35.00%

Revenue / Employee (TTM)$532,700

Tangible BV / Share (Quarterly)$0.11

P/S Ratio (Annual)0.55x

Asset Turnover (Annual)0.99x

52-Week High$1.56

Operating Margin (5Y Avg)-72.98%

EPS Excl Extra (Annual)$-0.83

CapEx CAGR (5Y)21.39%

Tangible BV CAGR (5Y)-36.08%

26-Week Price Return61.93%

Quick Ratio (Annual)3.40x

13-Week Price Return33.38%

Total Debt / Equity (Annual)8.82x

Current Ratio (Quarterly)2.99x

Enterprise Value$69.67M

Revenue / Share Growth (5Y)3.96%

Asset Turnover (TTM)1.17x

Book Value / Share Growth (5Y)-47.02%

Revenue / Employee (Annual)$535,200

Inventory Turnover (Annual)2.18x

Pretax Margin (Annual)-48.09%

Cash / Share (Annual)$1.14

3-Month Return Std Dev94.02%

Gross Margin (5Y Avg)66.50%

Net Income / Employee (TTM)$-274,500

ROE (Last FY)-615.10%

Net Interest Coverage (Annual)-4.87x

EPS Basic Excl Extra (Annual)$-0.83

Receivables Turnover (TTM)7.66x

Total Debt / Equity (Quarterly)8.82x

EPS Incl Extra (TTM)$-0.77

Receivables Turnover (Annual)7.85x

ROI (TTM)-72.25%

P/S Ratio (TTM)0.55x

Pretax Margin (5Y Avg)-80.53%

Revenue / Share (Annual)$1.71

Tangible BV / Share (Annual)$0.11

Price vs S&P 500 (52W)-50.53%

Year-to-Date Return-17.37%

5-Day Price Return-9.72%

EPS Normalized (Annual)$-0.83

ROA (5Y Avg)-53.94%

Net Profit Margin (Annual)-48.37%

Month-to-Date Return-15.22%

Cash Flow / Share (TTM)$-1.99

EBITD / Share (Annual)$-0.72

Operating Margin (Annual)-43.16%

LT Debt / Equity (Annual)8.82x

ROI (5Y Avg)-68.36%

LT Debt / Equity (Quarterly)8.82x

EPS Basic Excl Extra (TTM)$-0.77

P/TBV (Quarterly)10.61x

P/B Ratio (Annual)8.32x

Inventory Turnover (TTM)2.35x

Pretax Margin (TTM)-51.20%

Book Value / Share (Annual)$0.14

Price vs S&P 500 (13W)30.69%

Beta1.43x

Revenue / Share (TTM)$1.39

ROE (TTM)-441.55%

52-Week Low$0.50

vGradeB

gGradeC

mGradeB

vgmGradeC

TELA Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 10, 2026	-$0.18	-$0.20	-12.36%(-$0.02)
Q4 2025	Mar 24, 2026	-$0.18	-$0.17	+6.59%(+$0.01)
Q3 2025	Nov 13, 2025	-$0.20	-$0.19	+5.00%(+$0.01)
Q2 2025	Aug 11, 2025	-$0.18	-$0.22	-18.92%(-$0.04)

TELA Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.09

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
TELATELA Bio, Inc. Common Stock	B	C	B	0.6x	34.5%	67.1%	-43.7%	$0.97
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About TELA Bio, Inc. Common Stock

TELA Bio is a medical technology company focused on soft-tissue reconstruction for hernia repair and abdominal wall reconstruction. Its OviTex product portfolio is designed to leverage the body's natural healing response while reducing reliance on permanent synthetic materials. This approach aims to optimize clinical outcomes while preserving patient anatomy.

TELA Next Earnings Report

Report dateNov 12, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.15

Revenue estimate$20.03M

Also reporting on Nov 12, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

TELA Insider Transactions

BuySep 15, 2026
CAPPER JOSEPH H
Director
Shares: 75,000Value: $78,442
BuyAug 17, 2026
GETZ HEATHER C
Chief Executive Officer
Shares: 12,500Value: $8,311
BuyAug 14, 2026
GETZ HEATHER C
Chief Executive Officer
Shares: 15,000Value: $10,467

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

APTAlpha Pro Tech, Ltd.Orthopedic & Prosthetic Devices
COCHEnvoy Medical, Inc. Class A Common StockOrthopedic & Prosthetic Devices
MYOMyomo Inc.Orthopedic & Prosthetic Devices
POCIPrecision Optics Corporation, Inc. Common StockElectromedical Equipment
MBAIMBody AI Ltd. Ordinary ShareX-Ray Equipment
SYPRSypris Solutions IncIndustrial Instruments
MINDMIND Technology, Inc. Common Stock (DE)Defense Systems & Equipment
RPIDRapid Micro Biosystems, Inc. Class A Common StockLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$0.50

High$1.56